Biologic Effects and Basic Science of a Novel Immune-Modulation Therapy
- 6 June 2005
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 95 (11) , 24-29
- https://doi.org/10.1016/j.amjcard.2005.03.009
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Targeted Anticytokine Therapy in Patients With Chronic Heart FailureCirculation, 2004
- Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart FailureCirculation, 2003
- Renal Ischemia-reperfusion injury in the rat is prevented by a novel immune modulation therapyTransplantation, 2002
- The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1International Journal of Cardiology, 2000
- UV light affects cell membrane and cytoplasmic targetsJournal of Photochemistry and Photobiology B: Biology, 1998
- Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.Journal of Clinical Investigation, 1998
- Interleukin-1 in Myocardium and Coronary Arteries of Patients with Dilated CardiomyopathyJournal of Molecular and Cellular Cardiology, 1998
- Circulating concentrations of proinflammatory cytolcines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathyPublished by Elsevier ,1996
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric OxideScience, 1992